| Systematic (IUPAC) name | |
|---|---|
| (5α,6α)-6-methoxy- 17-methyl- 4,5-epoxymorphinan- 3-ol | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Schedule I (US) |
| Identifiers | |
| CAS number | 7732-92-5 |
| ATC code | None |
| PubChem | CID 5463907 |
| UNII | 26AY9TLO5W |
| Synonyms | Dihydroheterocodeine |
| Chemical data | |
| Formula | C18H23NO3 |
| Mol. mass | 301.38 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
Methyldihydromorphine (Dihydroheterocodeine)[1] is a semi-synthetic opioid drug developed in Germany in 1936, controlled under both domestic law and UN conventions because of its possible potential for abuse. Methyldihydromorphine is related to heterocodeine and is not a synonym for dihydrocodeine, and its structure suggests that it is six to nine times stronger than morphine and 72 times stronger than dihydrocodeine.
| This analgesic-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)